Retinitis pigmentosa is a blinding eye disease that affects approximately 150,000 individuals in the US and 1.5 million people around the world. It is caused by the destruction of light-sensing… ...

The statewide network is designed to overcome manufacturing bottlenecks that have delayed or stalled development and approval of regenerative medicines. “These awards are a critical first step in ...

San Diego, CA – A promising treatment for patients with spinal cord injuries and a therapy aimed at helping HIV patients create an AIDS-resistant blood system were approved today by the state’s stem ...

Most heart conditions leading to sudden death or impaired heart pumping functions in the young people ( 35 years old) are the results of genetic mutations inherited from parents. It is very difficult ...

Research Objective The research proposed here will support the development of NGL-101, a cell therapy for treating adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).

CIRM’s core programs focus on critical areas that drive the development and commercialization of regenerative medicine treatments. Spanning education, research, and funding opportunities, these ...

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

El cáncer es una de las principales causas de muerte en California. Las investigaciones han demostrado que muchos cánceres pueden propagarse por todo el cuerpo y resistir las terapias actuales contra ...

Bridges Dr. Lily Chen CIRM Bridges Science Master’s Program $3,606,500 Bridges Dr. Lily Chen CIRM Bridges 2.0: Training the Next Generation of Stem Cell Scientists $2,958,876 ...

Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...